Navigation Links
First CyberKnife System Sold in Switzerland
Date:4/11/2008

Renowned Clinic Invests in Extracranial Radiosurgery

SUNNYVALE, Calif., April 11 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced that the Hirslanden Clinic in Zurich, part of the renowned Hirslanden group of private hospitals, has purchased a CyberKnife System. This marks the first System sold in Switzerland, allowing patients greater access to the benefits of extracranial radiosurgery.

Since its beginning in the 1930s, the Hirslanden private hospital group has been a pioneer in the development of innovative treatment concepts. Hirslanden clinics continually adjust their medical and technical equipment according to current developments, as part of their contribution to improving the health and quality of life of their patients. The Hirslanden Clinic's purchase of a CyberKnife System is part of Hirslanden Hospital Group's further development of a stereotactic radiosurgery practice. The System will be utilized for both intracranial and extracranial treatments, particularly the non-invasive treatment of prostate cancer. Ideally the addition of the CyberKnife System will support the establishment of the Neurocenter Zurich, which will offer a full range of therapeutic options in neurological diseases.

"With the purchase of the CyberKnife, we can now offer the complete spectrum of a modern radiation-oncology program," said Dr. Christian von Briel, co-chairman of Hirslanden radiation-oncology "We are also very excited to start a scientific cooperation with the CyberKnife centre in Nice, France. We are confident that working with this academic hospital will be valuable for the development of our extracranial activity."

According to the
'/>"/>

SOURCE Accuray Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
3. Kewaunee Scientific Announces First Quarter Results and Quarterly Dividend
4. Genmab Announces 2007 First Half Year Results
5. Pharsight Achieves First License Sale for Public-Source Database
6. Novare Announces First Ever Single Port Laparoscopic Kidney Removal (Nephrectomy) Using RealHand(TM) HD Instruments
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. China Medical Technologies Reports First Quarter Financial Results
9. Pressure BioSciences, Inc. Issued First Patent in Canada
10. Peregrine Pharmaceuticals to Announce First Quarter FY 2008 Financial Results
11. Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... , July 6, 2015 Navitas, a leading Regulatory Service ... America hub in Bogota, Colombia . Navitas, ... the many benefits provided by Colombia , the third ... Logo - http://photos.prnewswire.com/prnh/20150703/228239LOGO ... location, allows US based clients to communicate with Navitas regulatory professionals in ...
(Date:7/5/2015)... ... July 06, 2015 , ... For many years, metal-on-quartz filters were the ... machine such as a Varian Cary 4000-7000, a Perkin Elmer 800-1100 or a Shimadzu ... even NIST used them for their SRM-2031 series going back for many years. Unfortunately, ...
(Date:7/3/2015)... 3, 2015 ... osoitteessa  http://www.openinnovationinscience.at Wienissä pidettävään ... Science" -jatkokoulutusohjelmaan 22.7.2015 asti.  ... tekemän, kansainvälisiä tutkijoita ja tiedemiehiä ... suurinta haastetta ovat kannustimien puute ...
(Date:7/3/2015)... ... 2015 , ... The global failure analysis market is expected to reach $7,147.0 ... market is expected to grow at the highest CAGR of 8.46%; its growth is ... research labs and academic institutions for root cause analysis of failure. The market based ...
Breaking Biology Technology:Navitas Launches Latin American Regulatory Operations Hub in Bogota, Colombia 2Navitas Launches Latin American Regulatory Operations Hub in Bogota, Colombia 3FireflySci Simplifies the Calibration of UV Spectrophotometers with FUV Photometric Accuracy Standards 2FireflySci Simplifies the Calibration of UV Spectrophotometers with FUV Photometric Accuracy Standards 3Maailman ensimmäinen tiedemiesten koulutukseen suunniteltu avoimen innovaation ohjelma käynnistyy 2Maailman ensimmäinen tiedemiesten koulutukseen suunniteltu avoimen innovaation ohjelma käynnistyy 3Failure Analysis Market to Grow at 7.52% CAGR to 2020 2Failure Analysis Market to Grow at 7.52% CAGR to 2020 3Failure Analysis Market to Grow at 7.52% CAGR to 2020 4Failure Analysis Market to Grow at 7.52% CAGR to 2020 5
... Caliper Life Sciences, Inc. (NASDAQ: CALP ... drug discovery and life sciences research for personalized medicine, ... meeting on May 17th and 18th.  This annual event ... diagnostics to discuss the technologies and discoveries that are ...
... ROCKVILLE, Md., May 5, 2011 Vanda Pharmaceuticals Inc. ... focused on the development and commercialization of products for ... results for the first quarter ended March 31, 2011. ... progress we have made to date in 2011," said ...
... PASADENA, Calif., May 4, 2011 Highlights ... from Operations ("FFO") Per Share (Diluted) Attributable to Alexandria Real ... 2011 Losses on Early Extinguishment of Debt, Up 6% Compared ... First Quarter 2011 Earnings Per Share (Diluted) Attributable to ...
Cached Biology Technology:Caliper Owners Group and Investor Meeting to Highlight Technologies Enabling Personalized Medicine 2Vanda Pharmaceuticals Reports First Quarter 2011 Results 2Vanda Pharmaceuticals Reports First Quarter 2011 Results 3Vanda Pharmaceuticals Reports First Quarter 2011 Results 4Vanda Pharmaceuticals Reports First Quarter 2011 Results 5Vanda Pharmaceuticals Reports First Quarter 2011 Results 6Vanda Pharmaceuticals Reports First Quarter 2011 Results 7Vanda Pharmaceuticals Reports First Quarter 2011 Results 8Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 2Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 3Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 4Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 5Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 6Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 7Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 8Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 9Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 10Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 11Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 12Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 13Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 14Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 15Alexandria Real Estate Equities, Inc. Reports First Quarter Ended March 31, 2011 Financial and Operating Results 16
(Date:7/2/2015)... DUBLIN , June 25, 2015 ... has announced the addition of the "Natural ... Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image ... to their offering. The key vendors ... Google, HP, IBM Corporation, Microsoft Corporation, NetBase Solutions, ...
(Date:6/29/2015)... 2015 Research and Markets( ... "Latin America Biomedical Sensors Market - Growth, Trends & ... The Latin America Biomedical Sensors market is estimated at ... over the period 2014-2020 The near future ... genetic formulation of each individual. These sensors can be ...
(Date:6/24/2015)... 2015 The biologics safety testing market is ... the market include growth of the pharmaceutical and biological ... Over the years, the number of drug approvals in ... the FDA approved 225 drug applications and Health Canada ... Europe accounted for 3,822 of the pharmaceutical ...
Breaking Biology News(10 mins):Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2Latin America Biomedical Sensors Market Report 2015-2020 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4
... new study in mice, a scientific collaboration centered at ... signaling breakdown in Angelman syndrome, a disorder that affects ... seizures, and other problems. With the new understanding, the ... works to restore neural functions impaired by the disease. ...
... FRANCISCO February 12, 2013 New findings from a ... predict whether a person is likely to develop age-related macular ... than nine million Americans, these genes do not predict how ... most widely used to treat the "wet" form of AMD. ...
... New Geology science posted online ahead of ... several sites in the U.S., as well as work ... southeastern Pacific, South Africa, and Mars. Tectonics, flooding, carbon ... Brief highlights follow. Papers cover , 1. ...
Cached Biology News:Study in mice yields Angelman advance 2Study in mice yields Angelman advance 3Study in mice yields Angelman advance 4Major clinical trial finds no link between genetic risk factors and 2 top wet AMD treatments 2The Geological Society of America Journal Geology: Dynamic geoscience 2The Geological Society of America Journal Geology: Dynamic geoscience 3The Geological Society of America Journal Geology: Dynamic geoscience 4The Geological Society of America Journal Geology: Dynamic geoscience 5The Geological Society of America Journal Geology: Dynamic geoscience 6The Geological Society of America Journal Geology: Dynamic geoscience 7The Geological Society of America Journal Geology: Dynamic geoscience 8The Geological Society of America Journal Geology: Dynamic geoscience 9The Geological Society of America Journal Geology: Dynamic geoscience 10The Geological Society of America Journal Geology: Dynamic geoscience 11The Geological Society of America Journal Geology: Dynamic geoscience 12The Geological Society of America Journal Geology: Dynamic geoscience 13The Geological Society of America Journal Geology: Dynamic geoscience 14The Geological Society of America Journal Geology: Dynamic geoscience 15
... reagents for immune complex disruption (ICD) of ... using a combination of low pH and ... transferred to microplate wells which are coated ... to HIV-1 p24. The immobilized monoclonal antibody ...
... DNA preparations are prepared from customers ... 1mg to multi-gram scales. Each preparation ... and glycerol stocks are maintained to ... selection (Clonal selection includes screening colonies ...
... hormones which belong to the transforming ... superfamily is a large group of ... aspects of development, reproductive function and ... TGF-s, bone morphogenetic proteins, growth differentiation ...
... System facilitates the display of custom peptide ... as coat protein fusions, creating a physical ... encoding DNA sequence. Peptide ligands for a ... by the straightforward method of biopanning. The ...
Biology Products: